Salix Pharmaceuticals Backs Out Of Cosmo Merger - Hedge Fund Alpha (formerly ValueWalk Premium)
salix pharmaceuticals

Salix Pharmaceuticals Backs Out Of Cosmo Merger

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) has backed out of a proposed Irish tax inversion with Italian firm Cosmo Pharmaceuticals S.p.A (SWX:COPN), taking a $25 million hit in the process, but also said the two companies will continue to do business together. Even though there hasn’t been any concrete move to change the rules around tax inversions, the fact that changes can be applied retroactively changes the calculation for any company thinking about a major reorganization done solely for tax purposes. “The changed political environment has created more uncertainty regarding the potential benefits we expected to achieve,” said Salix President and CEO Carolyn...

This content is exclusively for paying members of Hedge Fund Alpha

Gain Exclusive Access to the Insider Strategies and Letters to Shareholders from the Top Hedge Funds and Maximize Your Portfolio Growth with Hedge Fund Alpha

Get Started Now with a FREE 7-Day Trial🔻

If you are a current Hedge Fund Alpha member and are having an account error please clear cache and cookies. If that does not work, email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

Watch a FREE Behind the Scenes Training on the 3 Secrets to Finding Small Cap Stock Opportunities with Massive Growth Potential in 2024.

Click here to get the training